Logo-jrip
J Renal Inj Prev. 2017;6(1): 26-29. doi: 10.15171/jrip.2017.05
PMID: 28487868        PMCID: PMC5414515

Case Report

Severe symptomatic acute hyponatremia in traumatic brain injury responded very rapidly to a single 15 mg dose of oral tolvaptan; a Mayo Clinic Health System hospital experience – need for caution with tolvaptan in younger patients with preserved renal function

Macaulay Amechi Chukwukadibia Onuigbo 1 * , Nneoma Agbasi 2

Cited by CrossRef: 2


1- Liu Y, Tang J, Zhou M, Huang H, Wang T, Zhang M. Case report: Persistent syndrome of inappropriate antidiuresis after traumatic brain injury: spontaneous resolution and impact on RAAS and bone metabolism over five years. Front Endocrinol. 2025;15 [Crossref]
2- Bisiani A, Redmond J, Deane A, Plummer M. Vaptans for the Management of Hyponatremia in Neurocritical Care: a Systematic Review. SN Compr Clin Med. 2022;4(1) [Crossref]
3- Tudor R, Thompson C. Posterior pituitary dysfunction following traumatic brain injury: review. Pituitary. 2019;22(3):296 [Crossref]